Showing results (1-10 of 172) with videos related to
Sort By:
Pageof 18
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Viral vectors for cancer immunotherapyRichard Harrop, Miles W CarrollAdvanced Drug Delivery Reviews|October 13, 2006
Recombinant viral vectors: cancer vaccinesRichard Harrop, Justin John, Miles W CarrollMethods in Molecular Biology (Clifton, N.J.)|April 29, 2004
Monitoring of human immunological responses to vaccinia virusRichard Harrop, Matthew G Ryan, Hana Golding, et al.Immunology|April 25, 2006
Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4Irina Redchenko, Richard Harrop, Matthew G Ryan, et al.Cancer Immunology, Immunotherapy : CII|November 29, 2005
Active treatment of murine tumors with a highly attenuated vaccinia virus expressing the tumor associated antigen 5T4 (TroVax) is CD4+ T cell dependent and antibody mediatedRichard Harrop, Matthew G Ryan, Kevin A Myers, et al.Human Vaccines & Immunotherapeutics|April 9, 2013
Cancer vaccines: identification of biomarkers predictive of clinical efficacyRichard HarropCancer Immunology, Immunotherapy : CII|December 7, 2007
Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responsesRichard Harrop, Noel Drury, William Shingler, et al.Vaccine|March 26, 2013
Recombinant MVA vaccines: dispelling the mythsMatthew G Cottingham, Miles W CarrollClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trialRichard Harrop, Noel Connolly, Irina Redchenko, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Vaccination of colorectal cancer patients with modified vaccinia ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responsesRichard Harrop, Noel Drury, William Shingler, et al.Pageof 18